Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biomed Mater Res B Appl Biomater ; 94(1): 157-64, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20524190

RESUMO

A prospective randomized long-term follow-up study of bioactive glass (BG)-S53P4 and autogenous bone (AB) used as bone graft substitutes in benign bone tumor surgery during 1993-1997 was conducted. Twenty-one patients (11 in the BG group, 10 in the AB group) participated in a 14-year follow-up. X-rays and MRI scans were obtained, and in the BG group, CT scans were also performed. In the BG group, the filled cavity had a dense appearance on X-ray. MRI showed a mainly or partly fatty bone marrow, and in the large bone tumor group, remnants of glass granules were also observed. Increased cortical thickness was seen in nonossifying fibromas and enchondromas. BG-S53P4 is a safe and well-tolerated bone substitute with good long-term results. BG-S53P4 does not disturb the growth of bone in children.


Assuntos
Neoplasias Ósseas/cirurgia , Substitutos Ósseos , Transplante Ósseo , Vidro/química , Materiais Biocompatíveis/química , Materiais Biocompatíveis/metabolismo , Neoplasias Ósseas/diagnóstico por imagem , Neoplasias Ósseas/patologia , Substitutos Ósseos/química , Substitutos Ósseos/metabolismo , Transplante Ósseo/instrumentação , Transplante Ósseo/métodos , Criança , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Imageamento por Ressonância Magnética , Masculino , Estudos Prospectivos , Radiografia , Transplante Autólogo , Resultado do Tratamento
2.
J Biomed Mater Res B Appl Biomater ; 90(1): 131-6, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18988277

RESUMO

In a prospective randomized study, 25 patients with benign bone tumors were surgically treated with either bioactive glass S53P4 (BG) or autogenous bone (AB) as bone graft material. X-rays were taken preoperatively and postoperatively at 2 weeks and at 3, 8, 12, 18, 24, and 36 months. In addition, for most of the patients, CT scans were performed at the same time-points. No infections or material-related adverse reactions occurred in any patient. The filled cavity was replaced faster by new bone in the AB group than in the BG group (p = 0.0001). However, at 36 months, no statistical difference in cavity volume between the two groups was observed on X-rays (p = 0.7881) or on CT scans (p = 0.9117). In the BG group at 3 years, the filled cavity appeared, however, dense on X-rays, and glass granules on CT scans were observed. During the follow-up period, the cortical thickness seemed to increase more in the BG group than in the AB group (p < 0.0001).


Assuntos
Materiais Biocompatíveis , Neoplasias Ósseas/terapia , Substitutos Ósseos , Vidro , Desenvolvimento Ósseo , Neoplasias Ósseas/diagnóstico por imagem , Feminino , Humanos , Masculino , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...